Results 41 to 50 of about 36,896 (275)

Patient-reported outcomes measures and patient preferences for minimally invasive glaucoma surgical devices. [PDF]

open access: yes, 2020
BackgroundMany therapeutic options are available to glaucoma patients. One recent therapeutic option is minimally invasive glaucoma surgical (MIGS) devices. It is unclear how patients view different treatments and which patient-reported outcomes would be
George Spaeth   +17 more
core   +1 more source

Glaucoma: target intraocular pressures and current treatments [PDF]

open access: yesPrescriber, 2009
Abstract Our Drug review of glaucoma management describes the use of target intraocular pressures in directing treatment, and the medical, laser and surgical management options. This is followed by an analysis of prescription data and sources of further information.
openaire   +1 more source

Effects of Latanoprost 0.005%/Timolol Maleate 0.5% and Dorzolamide 2%/Timolol Maleate 0.5% Fixed Combinations on 24-hour Intraocular Pressure in Patients with Primary Open-Angle Glaucoma

open access: yesTürk Oftalmoloji Dergisi, 2012
Pur po se: To evaluate the effects of latanoprost/timolol maleate and dorzolamid/timolol maleate fixed combinations on-24 hours intraocular pressure in patients with open-angle glaucoma.
Berna Yüce   +3 more
doaj   +1 more source

From Bench to Bed: The Current Genome Editing Therapies for Glaucoma

open access: yesFrontiers in Cell and Developmental Biology, 2022
Glaucoma is a group of optic neuropathies featured by degeneration of retinal ganglion cells and loss of their axons in the optic nerve. The only currently approved therapies focus on lowering intraocular pressure with medication and surgery.
Meihui He   +11 more
doaj   +1 more source

Diagnosis and management of iridocorneal endothelial syndrome [PDF]

open access: yes, 2015
The iridocorneal endothelial (ICE) syndrome is a rare ocular disorder that includes a group of conditions characterized by structural and proliferative abnormalities of the corneal endothelium, the anterior chamber angle, and the iris.
Ambrosio, Oriella   +5 more
core   +2 more sources

Growth factor restriction impedes progression of wound healing following cataract surgery: identification of VEGF as a putative therapeutic target [PDF]

open access: yes, 2016
Secondary visual loss occurs in millions of patients due to a wound-healing response, known as posterior capsule opacification (PCO), following cataract surgery. An intraocular lens (IOL) is implanted into residual lens tissue, known as the capsular bag,
A Parenti   +44 more
core   +1 more source

Comparative study of intraocular pressure (IP) in Bangladeshi individuals by contact and non contact technique

open access: yesBangabandhu Sheikh Mujib Medical University Journal, 2016
Background: Intraocular pressure (IOP) is one of the most important parameters in the diagnosis and treatment of glaucoma. Glaucoma has been established as the second leading cause of blindness.
Sayed Abdul Wadud   +2 more
doaj   +1 more source

Surgery for normal tension glaucoma. Target intraocular pressure and visual field progression [PDF]

open access: yesActa Ophthalmologica Scandinavica, 1997
No abstract ...
Fontana L   +4 more
openaire   +3 more sources

Combined Femtosecond Laser Assisted Cataract Surgery and Pars Plana Vitrectomy

open access: yesThe Pan-American Journal of Ophthalmology, 2017
Purpose: Determine the benefits and challenges of combined femtosecond laser assisted cataract surgery with the Catalys® system (Abbott, Abbott Park, IL) and vitrectomy.
Brian Lee   +2 more
doaj   +3 more sources

Target Intraocular Pressure and Personalized Medicine in Glaucoma: Balancing Precision, Patient Autonomy, and Evolving Treatment Paradigms

open access: yesTNOA Journal of Ophthalmic Science and Research
The establishment of a target intraocular pressure (IOP) remains the cornerstone of therapeutic intervention in glaucoma. However, the paradigm for defining this target has shifted dramatically from a population-based threshold to a fluid, individualized
Shibal Bhartiya   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy